NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates 
U.S. Dollar Reaches One-Year High as Tech Sell-Off and Fed Rate Hike Expectations Support Demand 
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
SpaceX, Charter Communications Explore Mobile Partnership to Expand Starlink Wireless Service 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak 
China vs. NASA: The New Moon Race and What's at Stake by 2030 
Gold Falls Below $4,000 as Strong Dollar and Fed Rate Hike Expectations Weigh on Prices 
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies 
Wall Street Ends Lower as AI Stocks Drag Markets, Fed Rate Outlook Shifts 
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman 
Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge 
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship 
Asian Currencies Trade Mixed as Yen Hovers Near 40-Year Low, Dollar Holds Firm on Fed Outlook 
The Korea Photonics Technology Institute has developed a free-space augmented reality (AR) system that allows examination of breast cancer tissue’s location and shape through the naked eye.
The system, developed in collaboration with the institution, local AR developer Apros Corp., and the National Cancer Center, uses a small light projection device to broadcast a video of breast cancer captured by a camera onto the afflicted region for surgeons.
The near-infrared fluorescence probe video system that is typically used for breast cancer surgery does not allow surgeons to see the wavelength of the light generated by the fluorescent contrast agent with their naked eyes, necessitating the use of a separate monitor with a dedicated camera for the surgery.
The innovative method reflects real-time changes in the position of breast cancer cells caused by human tissue flexibility, and shows the video immediately on the affected area to aid the surgeon's attention, reducing the time spent on the surgery.
The new technology has passed performance tests utilizing National Cancer Center-created breast cancer models and animal testing, with medical certification and clinical trials scheduled for the near future.
